SCHEMBL9259435

SCHEMBL9259435

Cc1ncn(-c2ccc(C(C)C)cc2)c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 1/20 0.47
HPGD P15428 1/20 0.47
HIF1A Q16665 1/20 0.47
HSD17B10 Q99714 1/20 0.47
PTGS2 P35354 1/20 0.43
NOTUM Q6P988 2/20 0.43
TDP1 Q9NUW8 1/20 0.39
MGLL Q99685 1/20 0.39
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
LMNA P02545 3/20 0.38
POLB P06746 1/20 0.38
RECQL P46063 1/20 0.38
GRM5 P41594 1/20 0.38
GRM1 Q13255 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9262045 0.84 MKNK1 (0.47) ALDH1A1CYP1A2PTGS2NOTUMTDP1
SCHEMBL22143673 0.81 MKNK1 (0.52) ALDH1A1CYP1A2CYP2D6HPGDHIF1A
SCHEMBL19214262 0.81 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2D6HPGDHIF1A
SCHEMBL27399076 0.77 PTGS2 (0.51) ALDH1A1CYP1A2CYP2D6HPGDHIF1A
SCHEMBL22510633 0.76 ALDH1A1 (0.63) ALDH1A1CYP1A2CYP2D6HPGDHIF1A
SCHEMBL24784278 0.74 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2D6HPGDHIF1A
SCHEMBL29205308 0.74 ALDH1A1 (0.57) ALDH1A1CYP1A2CYP2D6HPGDHIF1A
SCHEMBL22185265 0.71 HSP90AA1 (0.42) PTGS2NOTUMGRM1RAB9A
SCHEMBL10022328 0.70 ALDH1A1 (0.57) ALDH1A1CYP1A2CYP2D6NOTUMTDP1
SCHEMBL25442241 0.70 CYP3A4 (0.51) CYP2D6PTGS2NOTUMTDP1MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND SHIONOGI & CO., LTD. (JP) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND BACE1, STS, APP ALDH1A1 3654/4885CYP1A2 1696/4885CYP2D6 464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.